Synergistic Antiproliferative Effects of All-Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nguyen, Q.T.T. | - |
dc.contributor.author | Hoang, T.X. | - |
dc.contributor.author | Ryu, Hyunjin | - |
dc.contributor.author | Oh, Kook-Hwan | - |
dc.contributor.author | Kim, Jae Young | - |
dc.date.accessioned | 2022-04-14T05:40:10Z | - |
dc.date.available | 2022-04-14T05:40:10Z | - |
dc.date.created | 2021-10-27 | - |
dc.date.issued | 2021-10-06 | - |
dc.identifier.issn | 2314-6133 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/83976 | - |
dc.description.abstract | Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by uncontrollable epithelial cell growth, cyst formation, and kidney malfunction. In the present study, we investigated the antiproliferative effects of the treatment with the combination of paclitaxel (PAC) and all-trans retinoic acid (ATRA) on ADPKD epithelial cells. Our results show that the combined treatment with 1 nM PAC and 10 nM ATRA significantly suppressed ADPKD cell proliferation (20%), while the treatment with ATRA or PAC alone had no such effect. Treatment with PAC and ATRA induced cell cycle arrest at the G2/M phase and apoptosis by upregulating p53 and caspase-8 expression and increased the intracellular calcium (Ca2+) level possibly by enhancing Ca2+ uptake via plasma membrane channels. In addition, this treatment suppressed extracellular signal-regulated kinase signaling possibly through mitogen-activated protein kinase phosphatase-1 activation. Thus, the combination of PAC and ATRA can be explored as a potential treatment regimen for ADPKD. © 2021 Que Thanh Thanh Nguyen et al. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Hindawi Limited | - |
dc.relation.isPartOf | BioMed Research International | - |
dc.title | Synergistic Antiproliferative Effects of All-Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000774763300001 | - |
dc.identifier.doi | 10.1155/2021/1242916 | - |
dc.identifier.bibliographicCitation | BioMed Research International, v.2021 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85117380323 | - |
dc.citation.title | BioMed Research International | - |
dc.citation.volume | 2021 | - |
dc.contributor.affiliatedAuthor | Nguyen, Q.T.T. | - |
dc.contributor.affiliatedAuthor | Hoang, T.X. | - |
dc.contributor.affiliatedAuthor | Kim, Jae Young | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | INDUCED APOPTOSIS | - |
dc.subject.keywordPlus | CANCER CELLS | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | CALCIUM | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | CYTOTOXICITY | - |
dc.subject.keywordPlus | GLIOBLASTOMA | - |
dc.subject.keywordPlus | COMBINATION | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.